More help for patients with less severe heart failure
Metadata[+] Show full item record
Prescribe a mineralocorticoid-receptor antagonist for patients with New York Heart Association (NYHA) Class II systolic heart failure and an ejection fraction (EF) ≤30%. Eplerenone has been found to decrease hospitalizations for heart failure and cardiovascular and all-cause mortality. Strength of recommendation: A: Based on one high-quality randomized controlled trial (RCT).
Journal of Family Practice, 60(8) 2011: 482+.